Login to Your Account



Kainos' Parkinson's drug may be first to target disease, not symptoms

By Pearl Liu
Staff Writer

Tuesday, October 6, 2015

HONG KONG – With a nod to proceed from the Korea Food and Drug Administration, Seoul-based Kainos Medicine Inc. is taking its Parkinson's disease candidate, KR-33493, into the clinic.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription